RegisterLogin

XMD-17-51 (TFA)

CAT: 804-HY-117291A-01Size: 5 mgDry Ice: NoHazardous: No
5 mgSelected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
XMD-17-51 TFA is a pyrimido-diazepinone compound that is able to modulate protein kinases[1].
CAS Number
[2436579-93-8]
UNSPSC
12352005
Target
AMPK; Bcr-Abl; ERK; Mps1; Polo-like Kinase (PLK) ; Trk Receptor
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; Epigenetics; MAPK/ERK Pathway; Neuronal Signaling; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/xmd-17-51-tfa.html
Purity
99.46
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1N(C)C2=CN=C(NC3=CN(C4CCNCC4)N=C3)N=C2N(C)C5=CC=CC=C15.OC(C(F)(F)F)=O
Molecular Formula
C23H25F3N8O3
Molecular Weight
518.49
References & Citations
[1]WO 2014145909 A2.|[2]Yang WQ, Zhao WJ, Zhu LL, et al. XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression. Front Pharmacol. 2021;12:603453.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-117291XMD-17-51
HY-15812-01XMD-12
HY-P1545A-01ACTH (1-17) (TFA)
HY-P5215LfcinB 17–28 (TFA)
HY-P1341AOXA (17-33) (TFA)
HY-101097APD-1-IN-17 (TFA)
HY-P10174A-01ADAM-17 Substrate (TFA)
HY-P1066AApelin-17 (human, bovine) (TFA)
HY-157382AChE-IN-51
HY-162842HPK1-IN-51

Alternative Products

CatalogName
M23725-01XMD-17-51
T22460XMD-17-51
MBS5756964XMD-17-51
561657XMD-17-51
C07051-01XMD-17-51
MBS3613390-01XMD-17-51
BUP21838XMD-17-51
T9191-01XMD-17-51 Trifluoroacetate
MBS3613762-01XMD-17-51 Trifluoroacetate
MBS5765661XMD-17-51 Trifluoroacetate

Popular Products